Skip to content
Search

Latest Stories

Only about one in five staff in UK cities return to workplaces, says think-tank

ONLY 17 per cent of workers in British cities had returned to their workplaces by early August, underscoring the challenge for Prime Minister Boris Johnson to steer the country away from its coronavirus shutdown, data published on Thursday (27) showed.

The Centre for Cities said the data, based on mobile phone signals, showed no increase in the footfall of workers going to city centres between late June and the week starting August 3.


Johnson last month encouraged people working from home to get back to their workplaces to help the economy recover from its 20 per cent contraction in the April-June period, the biggest fall among big developed economies.

"The costs of office closure are becoming clearer by the day," Carolyn Fairbairn, director-general of the Confederation of British Industry.

"Some of our busiest city centres resemble ghost towns, missing the usual bustle of passing trade. This comes at a high price for local businesses, jobs and communities."

Separate figures published by Britain's statistics office showed almost one in four businesses in accommodation and food services and arts, and the entertainment and recreation industries rated their risk of insolvency as moderate or severe.

The Office for National Statistics also said footfall in mid-August in high streets, retail parks and shopping centres had increased to around 70 per cent of its level a year earlier.

Vehicle traffic levels on August 24 were just six percentage points lower than in early February, before the pandemic struck.

More For You

MRI

Individuals with certain metabolic conditions may be more prone to this process

Getty

MRI injection linked to rare deadly health risk, study finds

A new study has raised concerns over the use of a common chemical injected during MRI scans, suggesting it may contribute to a potentially fatal complication in rare cases.

Researchers from the University of New Mexico have found that gadolinium – a toxic rare earth metal used in MRI contrast agents – can interact with oxalic acid found in many foods to form nanoparticles in human tissues. These particles could potentially lead to serious health problems affecting organs such as the kidneys.

Keep ReadingShow less
Morrisons

Morrisons has said it will continue to monitor customer feedback

Getty

Morrisons adds charity donation option to More Card loyalty scheme

Morrisons has announced a new update to its More Card loyalty programme, giving customers the option to donate their points to charity. The change, introduced on Monday 14 April, allows shoppers to convert their saved points into cash donations for Marie Curie, a UK charity that provides end-of-life care and support.

Under the new scheme, customers can donate their points in multiples of 1,000, which equates to a £1 value. Donations can be made easily through the More Card app or the official Morrisons website. Once submitted, the points are converted into their cash equivalent and passed directly to Marie Curie on behalf of the customer.

Keep ReadingShow less
‘UK, Take Notes’: British YouTuber Raves About Indian Train Meal

Many viewers were both amused and impressed by the efficiency of Indian railway food delivery

Instagram/ georgebxckley

British YouTuber’s train meal in India leaves him saying, 'UK, take notes'

A British content creator recently experienced a unique moment while travelling by train across India—receiving a food delivery directly to his seat. George Buckley, a travel and lifestyle influencer, captured the experience in a video, showing how a meal ordered through Zomato was delivered to him at Kanpur Central Station during a brief five-minute stop.

Buckley uploaded the video with a humorous caption: "The UK needs to take notes." In the clip, he documents the full process, from ordering to receiving the meal, and thanks a fellow Indian passenger who helped him. “It was great meeting you, my friend,” he wrote in appreciation.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less